Trial Profile

Comparative effects of Nebivolol and Carvedilol on orthostatic hypotension in hypertensive patients with type 2 diabetes mellitus (DIANECA).

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 11 Sep 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Carvedilol (Primary) ; Nebivolol (Primary)
Indications Hypertension
Focus Adverse reactions
Acronyms DIANECA
Sponsors Menarini

Most Recent Events

21 Jul 2012 Actual end date (8 Oct 2009) added as reported by European Clinical Trials Database record.
21 Jul 2012 HEXAL added as associations as reported in the European Clinical Trials Database record.
21 Jul 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com